Acarix A/S Total Assets
Acarix A/S total assets. Based on the latest financial reports, Acarix A/S (ACARIX) holds total assets worth Skr47.74 Million SEK (≈ $5.14 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see ACARIX market cap overview for the company's overall valuation and market capitalisation.
Total Assets of Acarix A/S (2014–2025)
Total assets of Acarix A/S from 2014 to 2025. This chart illustrates how Acarix A/S's total assets have evolved over time, based on quarterly financial data. See latest Acarix A/S stock price today for real-time trading data and today's change.
Acarix A/S - Asset Composition Analysis
Acarix A/S Total Assets Breakdown (December 2025)
Acarix A/S total assets breakdown as of December 2025. Acarix A/S's total assets of Skr47.74 Million consist of 85.8% current assets and 14.2% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 37.8% |
| Accounts Receivable | Skr16.75 Million | 34.7% |
| Inventory | Skr6.46 Million | 13.4% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr6.47 Million | 13.4% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Acarix A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ACARIX current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Acarix A/S's current assets represent 85.8% of total assets in 2025, a decrease from 88.4% in 2014.
- Cash Position: Cash and equivalents constituted 37.8% of total assets in 2025, down from 47.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 11.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 34.7% of total assets.
Acarix A/S Competitors by Total Assets
Key competitors of Acarix A/S based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Acarix A/S - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.67 | 8.63 | 6.45 |
| Quick Ratio | 9.12 | 7.22 | 5.78 |
| Cash Ratio | 0.00 | 6.26 | 5.26 |
| Working Capital | Skr38.32 Million | Skr39.31 Million | Skr30.05 Million |
Acarix A/S - Advanced Valuation Insights
This section examines the relationship between Acarix A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.11 |
| Latest Market Cap to Assets Ratio | 0.49 |
| Asset Growth Rate (YoY) | -40.2% |
| Total Assets | Skr48.33 Million |
| Market Capitalization | $23.63 Million USD |
Valuation Analysis
Below Book Valuation: The market values Acarix A/S's assets below their book value (0.49x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Acarix A/S's assets decreased by 40.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Acarix A/S (2014–2025)
The table below shows the annual total assets of Acarix A/S from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr48.33 Million ≈ $5.20 Million |
-40.16% |
| 2024-12-31 | Skr80.76 Million ≈ $8.69 Million |
+28.43% |
| 2023-12-31 | Skr62.88 Million ≈ $6.77 Million |
-9.49% |
| 2022-12-31 | Skr69.48 Million ≈ $7.48 Million |
-41.42% |
| 2021-12-31 | Skr118.60 Million ≈ $12.76 Million |
+31.86% |
| 2020-12-31 | Skr89.95 Million ≈ $9.68 Million |
+8.39% |
| 2019-12-31 | Skr82.98 Million ≈ $8.93 Million |
-12.83% |
| 2018-12-31 | Skr95.20 Million ≈ $10.24 Million |
-28.99% |
| 2017-12-31 | Skr134.06 Million ≈ $14.43 Million |
-22.64% |
| 2016-12-31 | Skr173.29 Million ≈ $18.65 Million |
+1012.09% |
| 2015-12-31 | Skr15.58 Million ≈ $1.68 Million |
-14.78% |
| 2014-12-31 | Skr18.28 Million ≈ $1.97 Million |
-- |
About Acarix A/S
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Au… Read more